JAM3 and acute myeloid leukemia: This would be consistent with results showing that PDX or AML cell line engraftment of JAM-C-expressing cells is only partially dependent on JAM-B expression by recipient mice and with results showing that silencing JAM-C expression is sufficient to decrease Src family kinase activation (111).